Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 285

1.

Pharmacokinetics of estrogen and progesterone in chronic kidney disease.

Anderson GD, Odegard PS.

Adv Chronic Kidney Dis. 2004 Oct;11(4):357-60. Review.

PMID:
15492972
[PubMed - indexed for MEDLINE]
2.

Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration.

Schindler AE, Bolt HM, Zwirner M, Hochlehnert G, Göser R.

Arzneimittelforschung. 1982;32(7):787-91.

PMID:
6289846
[PubMed - indexed for MEDLINE]
3.

17 beta-estradiol for postmenopausal estrogen replacement therapy.

Nichols KC, Schenkel L, Benson H.

Obstet Gynecol Surv. 1984 Apr;39(4):230-45.

PMID:
6717863
[PubMed - indexed for MEDLINE]
4.

Pharmacokinetics of oral micronized beta-estradiol in postmenopausal women receiving maintenance hemodialysis.

Stehman-Breen C, Anderson G, Gibson D, Kausz AT, Ott S.

Kidney Int. 2003 Jul;64(1):290-4.

PMID:
12787421
[PubMed - indexed for MEDLINE]
5.
6.

Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism.

Bhavnani BR.

Proc Soc Exp Biol Med. 1998 Jan;217(1):6-16. Review.

PMID:
9421201
[PubMed - indexed for MEDLINE]
7.

Pharmacokinetics of estrogen.

Stumpf PG.

Obstet Gynecol. 1990 Apr;75(4 Suppl):9S-14S; discussion 15S-17S. Review.

PMID:
2179793
[PubMed - indexed for MEDLINE]
8.

Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women.

Labrie F, Cusan L, Gomez JL, Côté I, Bérubé R, Bélanger P, Martel C, Labrie C.

Menopause. 2009 Jan-Feb;16(1):30-6. doi: 10.1097/gme.0b013e31817b6132.

PMID:
18820592
[PubMed - indexed for MEDLINE]
9.

Nonoral routes of estrogen administration.

Cedars MI, Judd HL.

Obstet Gynecol Clin North Am. 1987 Mar;14(1):269-98. Review.

PMID:
3306522
[PubMed - indexed for MEDLINE]
10.

Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.

Yasui T, Uemura H, Umino Y, Takikawa M, Saito S, Kuwahara A, Matsuzaki T, Maegawa M, Furumoto H, Miura M, Irahara M.

Maturitas. 2005 Jan 10;50(1):19-29.

PMID:
15590210
[PubMed - indexed for MEDLINE]
11.

Pharmacokinetics and pharmacodynamics of a novel estrogen delta8-estrone in postmenopausal women and men.

Bhavnani BR, Cecutti A, Gerulath A.

J Steroid Biochem Mol Biol. 1998 Oct;67(2):119-31.

PMID:
9877212
[PubMed - indexed for MEDLINE]
12.

Different effects of oral conjugated equine estrogens and transdermal estrogen on undercarboxylated osteocalcin concentration in postmenopausal women.

Yasui T, Uemura H, Tomita J, Umino Y, Yamada M, Kuwahara A, Matsuzaki T, Maegawa M, Miura M, Irahara M.

Menopause. 2006 Jul-Aug;13(4):651-9.

PMID:
16837887
[PubMed - indexed for MEDLINE]
13.

Comparison of the effects of a new conjugated oral estrogen, estradiol-3beta-glucoside, with oral micronized 17beta-estradiol in postmenopausal women.

Sweeney AT, Tangpricha V, Weinberg J, Malabanan AO, Chimeh FN, Holick MF.

Transl Res. 2006 Oct;148(4):164-70.

PMID:
17002918
[PubMed - indexed for MEDLINE]
14.

Hormone replacement therapy in menopausal women: Past problems and future possibilities.

Schmidt JW, Wollner D, Curcio J, Riedlinger J, Kim LS.

Gynecol Endocrinol. 2006 Oct;22(10):564-77. Review.

PMID:
17135036
[PubMed - indexed for MEDLINE]
15.

Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.

Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.

Metabolism. 2009 Jan;58(1):1-7. doi: 10.1016/j.metabol.2008.07.016.

PMID:
19059524
[PubMed - indexed for MEDLINE]
16.

Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.

Pluchino N, Genazzani AD, Bernardi F, Casarosa E, Pieri M, Palumbo M, Picciarelli G, Gabbanini M, Luisi M, Genazzani AR.

Gynecol Endocrinol. 2005 Mar;20(3):144-9.

PMID:
16019353
[PubMed - indexed for MEDLINE]
17.

Influence of the maturity of the vaginal epithelium upon the absorption of vaginally administered estradiol-17 beta and progesterone in postmenopausal women.

Pschera H, Hjerpe A, Carlström K.

Gynecol Obstet Invest. 1989;27(4):204-7.

PMID:
2744624
[PubMed - indexed for MEDLINE]
18.

Steady-state pharmacokinetics following application of a novel transdermal estradiol spray in healthy postmenopausal women.

Morton TL, Gattermeir DJ, Petersen CA, Day WW, Schumacher RJ.

J Clin Pharmacol. 2009 Sep;49(9):1037-46. doi: 10.1177/0091270009339187. Epub 2009 Jul 23.

PMID:
19628730
[PubMed - indexed for MEDLINE]
19.

Profiles of plasma estrogens, progesterone and their metabolites after oral or vaginal administration of estradiol or progesterone.

Nahoul K, Dehennin L, Jondet M, Roger M.

Maturitas. 1993 May;16(3):185-202.

PMID:
8515718
[PubMed - indexed for MEDLINE]
20.

Pharmacodynamics of oestrogens and progestogens.

de Lignières B, Silberstein S.

Cephalalgia. 2000 Apr;20(3):200-7. Review.

PMID:
10997774
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk